Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
  • Clinical Research and Public Health
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • Conversations with Giants in Medicine
    • Video Abstracts
  • Reviews
    • View all reviews ...
    • Complement Biology and Therapeutics (May 2025)
    • Evolving insights into MASLD and MASH pathogenesis and treatment (Apr 2025)
    • Microbiome in Health and Disease (Feb 2025)
    • Substance Use Disorders (Oct 2024)
    • Clonal Hematopoiesis (Oct 2024)
    • Sex Differences in Medicine (Sep 2024)
    • Vascular Malformations (Apr 2024)
    • View all review series ...
  • Viewpoint
  • Collections
    • In-Press Preview
    • Clinical Research and Public Health
    • Research Letters
    • Letters to the Editor
    • Editorials
    • Commentaries
    • Editor's notes
    • Reviews
    • Viewpoints
    • 100th anniversary
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • Conversations with Giants in Medicine
  • Video Abstracts
  • In-Press Preview
  • Clinical Research and Public Health
  • Research Letters
  • Letters to the Editor
  • Editorials
  • Commentaries
  • Editor's notes
  • Reviews
  • Viewpoints
  • 100th anniversary
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
RNA-binding protein PCBP2 regulates pancreatic β cell function and adaptation to glucose
Matthew W. Haemmerle, … , Louis R. Ghanem, Doris A. Stoffers
Matthew W. Haemmerle, … , Louis R. Ghanem, Doris A. Stoffers
Published June 17, 2024
Citation Information: J Clin Invest. 2024;134(12):e172436. https://doi.org/10.1172/JCI172436.
View: Text | PDF
Research Article Endocrinology

RNA-binding protein PCBP2 regulates pancreatic β cell function and adaptation to glucose

  • Text
  • PDF
Abstract

Glucose plays a key role in shaping pancreatic β cell function. Thus, deciphering the mechanisms by which this nutrient stimulates β cells holds therapeutic promise for combating β cell failure in type 2 diabetes (T2D). β Cells respond to hyperglycemia in part by rewiring their mRNA metabolism, yet the mechanisms governing these changes remain poorly understood. Here, we identify a requirement for the RNA-binding protein PCBP2 in maintaining β cell function basally and during sustained hyperglycemic challenge. PCBP2 was induced in primary mouse islets incubated with elevated glucose and was required to adapt insulin secretion. Transcriptomic analysis of primary Pcbp2-deficient β cells revealed impacts on basal and glucose-regulated mRNAs encoding core components of the insulin secretory pathway. Accordingly, Pcbp2-deficient β cells exhibited defects in calcium flux, insulin granule ultrastructure and exocytosis, and the amplification pathway of insulin secretion. Further, PCBP2 was induced by glucose in primary human islets, was downregulated in islets from T2D donors, and impacted genes commonly altered in islets from donors with T2D and linked to single-nucleotide polymorphisms associated with T2D. Thus, these findings establish a paradigm for PCBP2 in governing basal and glucose-adaptive gene programs critical for shaping the functional state of β cells.

Authors

Matthew W. Haemmerle, Andrea V. Scota, Mina Khosravifar, Matthew J. Varney, Sabyasachi Sen, Austin L. Good, Xiaodun Yang, Kristen L. Wells, Lori Sussel, Andrea V. Rozo, Nicolai M. Doliba, Louis R. Ghanem, Doris A. Stoffers

×

Figure 1

PCBP2 is posttranscriptionally upregulated in islets incubated with high glucose.

Options: View larger image (or click on image) Download as PowerPoint
PCBP2 is posttranscriptionally upregulated in islets incubated with high...
(A–C) Western blot and quantification showing PCBP2 levels in mouse islets from 7- to 9-week-old wild-type male mice incubated in 2.8 mM or 16.7 mM glucose for 48 hours (n = 3) (A) and 2.8 mM or 16.7 mM glucose for 24, 48, and 72 hours (n = 3) (B and C). (D) Decreased Pcbp2 transcript levels in mouse islets from 7- to 8-week-old wild-type male mice incubated with 16.7 mM glucose for 48 hours (n = 3). (E) Representative Western blot showing reduction in PCBP2 levels at indicated times after addition of cycloheximide (CHX) to mouse islets from 8- to 10-week-old wild-type male mice. CHX was added after culturing for 72 hours in 2.8 mM or 16.7 mM glucose. (F) Quantification of PCBP2 t1/2 in islets incubated with 2.8 mM or 16.7 mM glucose (n = 5). *P < 0.05, **P < 0.01 by Student’s 2-tailed t test (A, D, and F); and *P < 0.05, ***P < 0.001 by 2-way repeated-measures ANOVA with Holm-Šidák post hoc test (C).

Copyright © 2025 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts